Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

G2B at Pediatric Diffuse Midline Glioma International Meeting

Events

Gate2Brain was honored to participate in the Pediatric Diffuse Midline Glioma (DMG) International Meeting, hosted at the SJD Pediatric Cancer Center in Barcelona. This gathering united experts from Spain and the Pacific Pediatric Neuro Oncology Consortium (PNOC), encompassing both physicians and scientists specializing in the field of DMG.

The primary goal of this event was to enhance our current comprehension of DMG and pinpoint vulnerabilities within these tumors, with the ultimate objective of developing more effective therapies.

During the meeting, Gate2Brain had the privilege of contributing to the session focused on DMG Research and Clinical Trials. We presented our insights on “Gate2Brain Technology: From Discovery to Application in Pediatric Brain Tumors with an Intact Blood-Brain Barrier, such as DMGs.”

This experience offered a unique opportunity to stay abreast of the latest developments related to diffuse midline glioma and the ongoing initiatives dedicated to improving the prognosis of children and adolescents suffering from this devastating brain cancer.

We extend our heartfelt gratitude to Hospital Sant Joan de Déu Barcelona for this outstanding and purposeful  event.

October 18, 2023/by noticias
Tags: DMG, pediatriccancer, SJD
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/10/SJD.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-10-18 09:19:002024-02-20 05:48:37G2B at Pediatric Diffuse Midline Glioma International Meeting
You might also like
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
medicines beyond barriersG2BMedicines beyond barriers
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
G2B receives funding to accelerate its transfer to the market and society
Sometimes drugs need a bigger push to be more effective and reach their final destination:ExpansionThe drug booster to the brain
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Elena Canetti – Meet the Advisory BoardFinalist of EIT Health Wild Card Programme 2023
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}